Cargando…
Marrow-Infiltrating Lymphocytes – Role in Biology and Cancer Therapy
The past several years have witnessed the acceptance of immunotherapy into the mainstream of therapies for patients with cancer. This has been driven by the clinical successes of antibodies to the checkpoint inhibitors, CTLA-4 and PD-1, capable of imparting long-term remissions in several solid tumo...
Autores principales: | Borrello, Ivan, Noonan, Kimberly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812049/ https://www.ncbi.nlm.nih.gov/pubmed/27066005 http://dx.doi.org/10.3389/fimmu.2016.00112 |
Ejemplares similares
-
The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
por: Li, Ruonan, et al.
Publicado: (2023) -
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials
por: McCarthy, Patrick M., et al.
Publicado: (2023) -
Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma
por: Zheng, Xiaoqin, et al.
Publicado: (2021) -
Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy
por: Plesca, Ioana, et al.
Publicado: (2020) -
Spatial and Temporal Heterogeneity of Tumor-Infiltrating Lymphocytes in Advanced Urothelial Cancer
por: van Wilpe, Sandra, et al.
Publicado: (2022)